Search

everythinglearnresearchcommunity

for

Search:↓

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

Matrix effects in LC-MS can be managed but not completely avoided.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

OBEME effectively enhances wound healing and could be a promising carrier for skin treatments.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Oral isotretinoin may slightly improve acne but increases the risk of side effects like dry lips and skin; more research is needed to understand its full risks and benefits.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Emulgels are promising for delivering drugs topically due to their easy spreadability and stability.

Cedrol may help treat rheumatoid arthritis due to its anti-inflammatory and antioxidant effects.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

The minoxidil and finasteride foam remains stable and effective for 180 days at room temperature.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Mitotane changes steroid breakdown, affecting cortisol availability.

Effervescent formulations may improve minoxidil delivery, increasing effectiveness and reducing applications needed.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Efficient enzyme function relies on specific residue interactions and structural coordination.

The steroids allopregnanolone and allotetrahydrodeoxycorticosteron worsened absence seizures in rats.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Some types of hair loss can continue for a long time after recovering from a severe drug reaction known as DRESS.